Search

Your search keyword '"Renshaw, Andrew A."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Renshaw, Andrew A." Remove constraint Author: "Renshaw, Andrew A." Topic health Remove constraint Topic: health
78 results on '"Renshaw, Andrew A."'

Search Results

1. Exploring the College of American Pathologists Electronic Cancer Checklists: What They Are and What They Can Do for You

5. Root Cause Analysis of Amendments in Tumor Summaries

6. Challenges for Data Extraction From Narrative Pathology Reports

9. Do Synoptic Reports Add Value in Prostate Needle Biopsies?

10. Increasing cytotechnologist workload above 100 slides per day using the ThinPrep imaging system leads to significant reductions in screening accuracy

12. Updates and Customizations in Synoptic Reporting

14. Comparison of Accuracy and Speed of Information Identification by Nonpathologists in Synoptic Reports With Different Formats

15. The Cost of Synoptic Reporting

18. Atypical cells in fine-needle aspiration biopsy specimens of benign thyroid cysts

26. The human false-negative rate of rescreening Pap tests

29. Improved Intraoperative Smears

30. Interpretive Diagnostic Error Reduction in Surgical Pathology and Cytology: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center and the Association of Directors of Anatomic and Surgical Pathology

31. Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

33. Effusion cytology of renal cell carcinoma

34. Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy

36. Effusion cytology of esophageal carcinoma

40. Fine-needle aspiration of chromophobe renal cell carcinoma: analysis of six cases

41. Fine-needle aspiration of the adult kidney

43. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

44. Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure

45. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

46. Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

47. Strategies for improving gynecologic cytology screening

49. Choosing battles or excuses in gynecology cytology

Catalog

Books, media, physical & digital resources